Tumale, Glysa .

HRN: 27-34-06  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
CEFUROXIME 1.5GM (VIAL)
06/24/2025
06/24/2025
IV
1.5g
PTOR
For OR
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: